Molecular diagnosis of bloodstream infections in onco-haematology patients with PCR/ESI-MS technology-Reference-Cited by-同舟云学术

Molecular diagnosis of bloodstream infections in onco-haematology patients with PCR/ESI-MS technology

Published:2017-02 Issue:2 Volume:74 Page:187-194
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Jordana-Lluch Elena,Rivaya Belén,Marcó Clara,Giménez Montserrat,Quesada Mª Dolores,Escobedo Agustín,Batlle Montserrat,Martró Elisa^ORCID,Ausina Vicente

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference32 articles.

1. Infections in the neutropenic patient–new views of an old problem;Donowitz;Hematol Am Soc Hematol Educ Program,2001

2. Bloodstream infections in neutropenic cancer patients: a practical update;Gustinetti;Virulence,2016

3. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock;Kumar;Chest,2009

4. Ibis T5000: a universal biosensor approach for microbiology;Ecker;Nat Rev,2008

5. New technology for rapid molecular diagnosis of bloodstream infections;Ecker;Expert Rev Mol Diagn,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of T2Bacteria in relationship to blood cultures - a retrospective comparative study;European Journal of Clinical Microbiology & Infectious Diseases;2024-08-03

2. Point-of-Care Method T2Bacteria®Panel Enables a More Sensitive and Rapid Diagnosis of Bacterial Blood Stream Infections and a Shorter Time until Targeted Therapy than Blood Culture;Microorganisms;2024-05-11

3. A Systematic Literature Review to Identify Diagnostic Gaps in Managing Immunocompromised Patients With Cancer and Suspected Infection;Open Forum Infectious Diseases;2023-12-07

4. The Role of Bacterial and Fungal Superinfection in Critical COVID-19;Viruses;2022-12-14

5. Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience;BMC Infectious Diseases;2022-02-01